{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T06:10:18Z","timestamp":1733724618415,"version":"3.30.1"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,1,5]],"date-time":"2002-01-05T00:00:00Z","timestamp":1010188800000},"content-version":"vor","delay-in-days":1434,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet Pharm &amp; Therapeutics"],"published-print":{"date-parts":[[1998,2]]},"abstract":"<jats:p>Isolated equine digital veins (EDVs) which had been denuded of their endothelium were used to study adenosine receptors causing vasodilation. When the blood vessel wall tension was raised with the thromboxanemimetic, U44069 (30 n<jats:sc>m<\/jats:sc>), the order of vasodilator potency of adenosine receptor agonists was: 5\u2032\u2010N\u2010ethylcarboxamidoadenosine (NECA) &gt; 2\u2010<jats:italic>p<\/jats:italic>\u2010(2\u2010carboxyethyl)phenyl amino\u20105\u2032\u2010N\u2010ethylcarboxamido\u2010adenosine (CGS 21680) &gt; 5\u2032\u2010N\u2010methylcarboxamido\u2010adenosine (MECA) &gt; &gt; N<jats:sup>6<\/jats:sup>\u2010cyclohexyladenosine (CHA) &gt; N<jats:sup>6<\/jats:sup>\u2010cyclopentyladenosine (CPA) &gt; N<jats:sup>6<\/jats:sup>\u20132\u2010(4\u2010Aminophenyl)ethyladenosine (APNEA) &gt; adenosine. Removal of the endothelium had no significant effect on the responses to NECA. The adenosine receptor antagonists, 8\u2010cyclopentyl\u20101,3\u2010dipropylxanthine (DPCPX; A<jats:sub>1<\/jats:sub>\u2010selective) and xanthine amine cogener (XAC; non\u2010selective antagonist) inhibited responses to NECA and CHA in a competitive manner and XAC proved to be 8\u201325 times more potent than DPCPX against both agonists. These data support the presence of A<jats:sub>2<\/jats:sub>adenosine receptors in EDVs, located on the vascular smooth muscle cells, which are most likely to be of the A<jats:sub>2A<\/jats:sub>\u2010adenosine receptor subtype. A direct comparison between the potency and efficacy of NECA and adenosine as vasodilators of EDV and equine digital arteries was made and both agonists proved to be significantly more potent and efficacious as vasodilators of EDVs. These data suggest that adenosine may be an important local mediator regulating blood flow through the digital circulation and that its generation under hypoxic conditions would lead to selective venodilation.<\/jats:p>","DOI":"10.1046\/j.1365-2885.1998.00106.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T09:20:27Z","timestamp":1047460827000},"page":"74-81","source":"Crossref","is-referenced-by-count":7,"title":["Characterization of vasodilatory adenosine receptors in equine digital veins"],"prefix":"10.1111","volume":"21","author":[{"family":"ELLIOTT","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"BRADY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,4,20]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"H1672","article-title":"Role of nitric oxide in adenosine receptor\u2010mediated relaxation of porcine coronary artery.","volume":"269","author":"Abebe W.","year":"1995","journal-title":"American Journal of Physiology"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1994.tb14042.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb16035.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2460\/ajvr.1990.51.12.1930","article-title":"Evaluation of equine digital Starling forces and haemodynamics during early laminitis.","volume":"51","author":"Allen D.","year":"1990","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.79.6.1153"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(94)90480-4"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1982.tb09231.x"},{"key":"e_1_2_6_9_2","first-page":"1551","article-title":"Plasma volume, electrolyte and endocrine changes during the onset of laminitis hypertension in horses.","volume":"43","author":"Clarke L.L.","year":"1982","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(83)90529-0"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-3306.1994.tb04407.x"},{"key":"e_1_2_6_12_2","unstructured":"Evans S.&Elliott J.(1994)A study of the vasodilator properties of propentophylline in equine isolated digital blood vessels.InProceedings of 6th International Congress EAVPT Ed. P. Lees. pp184185. Blackwell Science Edinburgh."},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","unstructured":"Furchgott R.F.(1972)The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory.InCatecholamines\u2010Handbook of Experimental Pharmacology.Eds Blashko H. & Muscoll E. Vol. 33 pp.283335.Springer\u2010Verlag Berlin.","DOI":"10.1007\/978-3-642-65249-3_9"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1993.tb01012.x"},{"key":"e_1_2_6_15_2","first-page":"47","article-title":"CGS 2168C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.","volume":"251","author":"Hutchison A.J.","year":"1989","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_6_16_2","first-page":"888","article-title":"[3H]CGS 21860, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.","volume":"251","author":"Jarvis M.F.","year":"1989","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_6_17_2","first-page":"197.","article-title":"Ischemia\u2010induced vasoconstriction and adenosine release in perfused human placental cotyledons. (Abstract).","volume":"29","author":"Kitagawa H.","year":"1987","journal-title":"Pharmacologist"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.3.518"},{"key":"e_1_2_6_19_2","first-page":"316","article-title":"Ligand selectivity of dog coronary adenosine receptor resembles that of adenylate cyclase stimulatory (Ra) receptors.","volume":"227","author":"Kusachi S.","year":"1983","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1995.269.2.C519"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(94)90011-6"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)90365-B"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0739(17)30604-1"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0033-0620(87)90003-X"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1990.70.3.761"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0165-6147(96)80010-1","article-title":"Pharmacology of adenosine A2A receptors.","volume":"17","author":"Ongini E.","year":"1996","journal-title":"Trends in Pharmacological Science"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(95)00044-7"},{"key":"e_1_2_6_28_2","first-page":"F678","article-title":"Effects of adenosine infusion into renal interstitium on renal haemodynamics.","volume":"252","author":"Pawlowska D.","year":"1987","journal-title":"American Journal of Physiology,"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(89)90074-5"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15341.x"},{"key":"e_1_2_6_31_2","first-page":"398","article-title":"The non\u2010xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.","volume":"276","author":"Zocchi C.","year":"1996","journal-title":"Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["Journal of Veterinary Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2885.1998.00106.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2885.1998.00106.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1365-2885.1998.00106.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2885.1998.00106.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T04:59:46Z","timestamp":1733720386000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2885.1998.00106.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["10.1046\/j.1365-2885.1998.00106.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2885.1998.00106.x","archive":["Portico"],"relation":{},"ISSN":["0140-7783","1365-2885"],"issn-type":[{"type":"print","value":"0140-7783"},{"type":"electronic","value":"1365-2885"}],"subject":[],"published":{"date-parts":[[1998,2]]}}}